# NCT06341114 (NCT06341114)

> A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06341114
- Phase: PHASE1, PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Bio-Thera Solutions
- Conditions: Advanced Solid Tumors
- Interventions: BAT8008 injection; BAT1308 injection
- Enrollment: 112
- Primary outcome: Dose-limiting toxicity (DLT)
- Primary outcome: vital signs
- Primary outcome: Physical examination
- Primary outcome: Adverse events
- Primary outcome: Clinical laboratory tests
- Primary outcome: Clinical auxiliary tests
- Primary outcome: Objective response rate (ORR)
- Primary outcome: Duration of Response(DOR)
- Primary outcome: Disease Control Rate (DCR)
- Primary outcome: Progression Free Survival(PFS)
- Primary outcome: Overall Survival(OS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct06341114